ePurines

ePurines, LLC is a drug development company specializing in innovative purinergic-based therapies aimed at treating obesity, metabolic syndrome, renal, and liver diseases. The company's core technologies were developed in the VA labs and are patented by the US Department of Veterans Affairs. ePurines leverages these patented technologies to create unique drug platforms that target purinergic signaling, a key pathway involved in various diseases. The company primarily serves US Veterans and the general population, focusing on improving health outcomes through cutting-edge scientific research and development. ePurines operates in the pharmaceutical and biotechnology market, utilizing a business model that combines state-of-the-art technology, innovation, and the expertise of its scientists to develop novel drug targets. Revenue is generated through drug development, licensing agreements, and potential collaborations and investment opportunities.

Keywords: purinergic signaling, drug development, obesity, metabolic syndrome, renal diseases, liver diseases, US Veterans, patented technology, biotechnology, pharmaceutical.